Industry/FDA Biomaterials Forum Postponed Indefinitely By Science Board
This article was originally published in The Gray Sheet
Executive Summary
The planning committee of the industry/FDA/National Institutes of Health/academia "Biomaterials Forum" has been directed to report back to FDA's Science Board within one year on the effects of its decision to postpone the project indefinitely.